An isogenic cell line was created to model cancer patients with the echinoderm microtubule-associated protein-like 4 (EML4)-anaplastic lymphoma kinase (ALK) fusion oncogene and tested for its ...

Roche's Alecensa has been recommended for routine NHS use as an adjuvant treatment for ALK-positive non-small cell lung cancer (NSCLC), the first targeted therapy for this indication. Alecensa ...

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Alectinib, also known as Alecensa, is recommended as an option for the treatment of stage 1B (tumours 4cm or larger) to 3A ALK-positive non-small-cell lung cancer (NSCLC) after surgery to completely ...

Alkaline phosphatase (ALP) is an enzyme present in many parts of your body. An ALP blood test checks the amount of this enzyme in your blood, mainly from your liver and bones. High levels may be a ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces ...

Projection is an analytical tool that visualizes the expected change in an asset's price in the next 90 days based on activity in the options market.